A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Summary

The primary objective of this study is to evaluate the long term safety and tolerability of ALKS 3831 in subjects with schizophrenia.

Timeline

Start

2016-01-20

Primary completion

2018-06-29

Completion

2018-06-29

Publications

• McIntyre RS, Matthews DM, Arevalo C, McDonnell D, Correll CU. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia. J Clin Psychiatry. 2026 Mar 9;87(2):25m16170. doi: 10.4088/JCP.25m16170.

Drugs

Indications